Advanced Search: SCLC

For more information about any of the clinical trials listed on this site, call 314-747-7222 or 800-600-3606 toll free or email

Select Basic Search to view clinical trials grouped by category and Advanced Search to be able to further narrow search results.



Phase 1 Study of SC-011 as a Single-Agent and in Combination with an Immunoregulatory Molecule in Subjects with Relapsed or Refractory Small Cell Lung Cancer (SCLC)


MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)


A phase II study of maintenance vorolanib and atezolizumab in patients with extensive-stage SCLC


Phase II Study of a Personalized Neoantigen Vaccine in Combination with Durvalumab (MEDI4736) in Extensive Stage Small Cell Lung Cancer


A Phase 1 Study Evaluating the Safety, Tolerability, and Pharmacokinetics of AMG 757 in Subjects with Small Cell Lung Cancer


A Firstin-human Phase I, non-randomized, open-label, multicenter dose escalation trial of BI 764532 administered by repeated intravenous infusions in patients with Small Cell Lung Carcinoma and other neuroendocrine neoplasms expressing DLL3